IL6 and neoplasm: While non-tumor bearing CD3 HuT mice showed no evidence of systemic cytokine response or histopathology resultant from inflammation, cynomolgus monkeys treated with the high affinity monovalent anti-LYPD1 TCB VHP354 showed marked increases in IL6 levels indicative of CRS.